1. Home
  2. CLLS vs PCYO Comparison

CLLS vs PCYO Comparison

Compare CLLS & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • PCYO
  • Stock Information
  • Founded
  • CLLS 1999
  • PCYO 1976
  • Country
  • CLLS France
  • PCYO United States
  • Employees
  • CLLS N/A
  • PCYO N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • PCYO Water Supply
  • Sector
  • CLLS Health Care
  • PCYO Utilities
  • Exchange
  • CLLS Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • CLLS 299.0M
  • PCYO 267.7M
  • IPO Year
  • CLLS 2007
  • PCYO N/A
  • Fundamental
  • Price
  • CLLS $3.49
  • PCYO $10.97
  • Analyst Decision
  • CLLS Buy
  • PCYO
  • Analyst Count
  • CLLS 1
  • PCYO 0
  • Target Price
  • CLLS $8.00
  • PCYO N/A
  • AVG Volume (30 Days)
  • CLLS 212.5K
  • PCYO 51.5K
  • Earning Date
  • CLLS 11-03-2025
  • PCYO 11-12-2025
  • Dividend Yield
  • CLLS N/A
  • PCYO N/A
  • EPS Growth
  • CLLS N/A
  • PCYO 123.89
  • EPS
  • CLLS N/A
  • PCYO 0.56
  • Revenue
  • CLLS $63,438,000.00
  • PCYO $27,447,000.00
  • Revenue This Year
  • CLLS N/A
  • PCYO N/A
  • Revenue Next Year
  • CLLS $66.76
  • PCYO N/A
  • P/E Ratio
  • CLLS N/A
  • PCYO $19.74
  • Revenue Growth
  • CLLS 223.09
  • PCYO 40.36
  • 52 Week Low
  • CLLS $1.10
  • PCYO $9.65
  • 52 Week High
  • CLLS $5.48
  • PCYO $14.63
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 47.81
  • PCYO 50.61
  • Support Level
  • CLLS $3.39
  • PCYO $10.93
  • Resistance Level
  • CLLS $5.48
  • PCYO $11.09
  • Average True Range (ATR)
  • CLLS 0.38
  • PCYO 0.17
  • MACD
  • CLLS -0.10
  • PCYO -0.02
  • Stochastic Oscillator
  • CLLS 6.38
  • PCYO 39.53

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: